Author
Listed:
- Gabriel E. Hoffman
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Brigham J. Hartley
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Erin Flaherty
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Ian Ladran
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Peter Gochman
(National Institutes of Health)
- Douglas M. Ruderfer
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Vanderbilt University Medical Center)
- Eli A. Stahl
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Judith Rapoport
(National Institutes of Health)
- Pamela Sklar
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
- Kristen J. Brennand
(Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai)
Abstract
The power of human induced pluripotent stem cell (hiPSC)-based studies to resolve the smaller effects of common variants within the size of cohorts that can be realistically assembled remains uncertain. We identified and accounted for a variety of technical and biological sources of variation in a large case/control schizophrenia (SZ) hiPSC-derived cohort of neural progenitor cells and neurons. Reducing the stochastic effects of the differentiation process by correcting for cell type composition boosted the SZ signal and increased the concordance with post-mortem data sets. We predict a growing convergence between hiPSC and post-mortem studies as both approaches expand to larger cohort sizes. For studies of complex genetic disorders, to maximize the power of hiPSC cohorts currently feasible, in most cases and whenever possible, we recommend expanding the number of individuals even at the expense of the number of replicate hiPSC clones.
Suggested Citation
Gabriel E. Hoffman & Brigham J. Hartley & Erin Flaherty & Ian Ladran & Peter Gochman & Douglas M. Ruderfer & Eli A. Stahl & Judith Rapoport & Pamela Sklar & Kristen J. Brennand, 2017.
"Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains,"
Nature Communications, Nature, vol. 8(1), pages 1-15, December.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-02330-5
DOI: 10.1038/s41467-017-02330-5
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-02330-5. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.